About the Role
As Co-founder & CEO, you will lead the commercial and company-building efforts for an AI-driven drug discovery platform, guiding it from spin-out through multiple funding rounds and market establishment. You will work closely with technical co-founders to shape strategy, build the commercial engine, and scale the company.
Responsibilities
- Shape strategy and positioning alongside the founding team.
- Lead fundraising: run a competitive seed round and the path to Series A.
- Build the commercial engine: partnerships, pilots and paying customers across pharma and biotech.
- Build the company: hiring, story, board, grant and academic partnerships, and day-to-day operations.
Requirements
- World-class expertise in a related technical field (AI, ML, therapeutics, etc.).
- Either you've personally led a priced round, or your name and track record make one raisable.
- US or UK based (or flexible on moving) and able to go full-time from spin-out.
Skills
- AI
- ML
- Therapeutics
- Commercial strategy
- Fundraising
- Business development
- Company building
- Team leadership
- Investor relations
- Partnership development
Location
- UK-based
- Hybrid
Work Type
- Full-time
- Hybrid
Experience Level
- Experienced founder and operator
- Scale a company from seed to Series A and beyond
Benefits
- Meaningful co-founder equity, milestone-linked.
- Access to proprietary venture-building tools, resources and processes.
- Access to DSV's global network of investors, advisors and industrial partners.
- A proven, working platform and a hard technical moat already in place.
- Continuous post-spinout support including fundraising, commercial partnerships, recruitment and team-building.
About the Company
- We're building the AI that fixes drug discovery: a scalable closed-loop agentic system that does the scientific reasoning and analysis end-to-end, generating traceable and verifiable predictions and decisions.
- Deep Science Ventures (DSV) is on a mission to create a future in which both humans and the planet can thrive.
- DSV is a leading deep-tech venture studio with a portfolio of 50+ science-led companies at a total valuation of ~$700m.
- Operating across Pharmaceuticals, Climate, Agriculture, and Computation, we tackle the challenges defining these areas by taking a first-principles approach and partnering with leading institutions.
